ES2844153T3

High dose levodopa capsules for pulmonary use

Abstract

A capsule for use in an inhalation device wherein said capsule is filled with a dry powder comprising levodopa wherein the capsule shell comprises hydroxypropylmethylcellulose (HPMC) and titanium dioxide.

ES2844153T3, drawing sheet 1
Sheet 1 of 5

Term

7.1 yearsto projected expiry

Projected expiry 8 November 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

5 sheets

  1. Sheet 1
  2. Sheet 2
  3. Sheet 3
  4. Sheet 4
  5. Sheet 5